Colgate-Palmolive Company 10-K Summary (Fiscal Year Ended Dec 31, 1995)
Business Context and Reporting Period
This Form 10-K covers the fiscal year ended December 31, 1995. Colgate-Palmolive Company is a global manufacturer and marketer of consumer products, primarily operating in two segments: Oral, Personal and Household Care, and Pet Nutrition (Hill's Pet Nutrition). The company operates in over 70 countries with 338 facilities worldwide. The reporting period was significantly impacted by a major worldwide restructuring initiative announced in September 1995 and the acquisition of the Kolynos oral care business in Latin America.
Key Financial Metrics
| Metric | 1995 | 1994 | 1993 |
|---|---|---|---|
| Net Sales | $8,358.2 million | $7,587.9 million | $7,141.3 million |
| Gross Profit | $4,005.1 million | $3,674.6 million | $3,411.4 million |
| Gross Margin | 47.9% | 48.4% | 47.8% |
| Net Income | $172.0 million | $580.2 million | $189.9 million |
| Diluted EPS | $1.02 | $3.56 | $1.05 |
| Operating Cash Flow | $810.2 million | $829.4 million | $710.4 million |
| Long-Term Debt | $2,992.0 million | $1,751.5 million | $1,532.4 million |
| Total Assets | $7,642.3 million | $6,142.4 million | $5,761.2 million |
| Shareholders' Equity | $1,679.8 million | $1,822.9 million | $1,875.0 million |
Material Changes vs. Prior Period
- Revenue Growth: Worldwide net sales increased 10% to $8,358.2 million, driven by acquisitions (Kolynos), new product introductions, and geographic expansion. Excluding acquisitions and divestitures, organic sales grew 8%.
- Earnings Decline: Net income dropped significantly to $172.0 million from $580.2 million in 1994. This decline was primarily due to a one-time pretax restructuring charge of $460.5 million ($369.2 million net of tax) and the dilutive impact of the Kolynos acquisition.
- Excluding Restructuring: On an adjusted basis excluding the restructuring charge, earnings were $541.2 million ($3.58 per share), a decrease of approximately 7% compared to 1994's $580.2 million.
- Debt Increase: Long-term debt increased by $1.25 billion to $3.029 billion (including reclassified short-term debt) to finance the Kolynos acquisition and other strategic investments.
- Segment Performance: The Oral, Personal and Household Care segment saw sales rise 12%. The Pet Nutrition segment sales declined due to the sale of non-core businesses in 1994 and a strategic realignment at Hill's Pet Nutrition.
Guidance, Outlook, and Risks
- Restructuring Program: The company announced a plan to close or reconfigure 24 of 112 factories and reduce the global workforce by approximately 3,000 employees (8.5%). Savings are expected to begin in late 1996 and reach $100 million annually by 1998.
- Outlook: Management expects strong growth in developing markets (Asia, Latin America) but notes economic uncertainty in Mexico and Venezuela may temper results. Competitive pressures in Western Europe are expected to persist.
- Acquisition Review: The Kolynos acquisition is under review by antitrust authorities in Brazil; management believes approval will eventually be granted.
- Dividends: Common dividends increased 15% to $1.76 per share in 1995.
- Risks: Key risks include foreign currency fluctuations, economic downturns in key markets (specifically Mexico), and the successful integration of acquired businesses.
Investor Verification Checklist
- Restructuring Impact: Verify the timeline and actual cost savings realized from the $460.5 million restructuring charge announced in Q3 1995.
- Kolynos Integration: Monitor the status of the antitrust review in Brazil and the financial performance of the Kolynos brand in Latin America.
- Debt Servicing: Assess the impact of the increased debt load ($3.0 billion) on future interest expenses and liquidity, given the higher effective interest rates.
- Adjusted Earnings: Compare reported earnings ($1.02 EPS) against adjusted earnings ($3.58 EPS) to understand the core operational performance versus one-time charges.
- Regional Exposure: Review specific performance data for Mexico and Venezuela to gauge the severity of the economic downturns mentioned in the outlook.